Abstract:Abstract Background Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age. This disease is also a metabolic disorder because of the high prevalence of accompanying metabolic disturbances, which might pose a high long-term risk of diabetes. The aims of this study were to analyse the prevalence, prognosis, and risk factors of insulin resistance, impaired glucose tolerance, and diabetes in Chinese patients with polycystic ovary syndrome. Methods Data recorded from July, 1998, to December, 2015, of patients with polycystic ovary syndrome were extracted from the database of our department; patients without relevant data were excluded. Retrospective analysis of data was done from first visit versus last follow-up. Polycystic ovary syndrome was diagnosed according to the Rotterdam 2003 criteria. Homeostatic model assessment-insulin resistance was 2·14 mIU/L or higher and fasting insulin of 11·87 mIU/L or higher. Abnormal glucose metabolism included impaired glucose tolerance (IGT) and type 2 diabetes diagnosed according to the 2006 WHO criteria. Disease regression was patients with baseline insulin resistance reversed to non-insulin resistance, or those with baseline IGT reversed to non-IGT at follow up. Cox regression analysis was used for hazard ratios (HRs) of variables for prognosis of insulin resistance or abnormal glucose metabolism. The cutoff value of insulin or glucose concentration was set to the 75th percentile of the value in referential groups. Findings 2931 patient records with all the relevant data were selected for analysis. The mean patient age at baseline was 26 years (SD 5·28, range 12–43). The mean follow up time was 2·18 years (SD 2·25; range 0·1–16·0). There was no effect on prognosis of insulin resistance and abnormal glucose metabolism with clinical polycystic ovary syndrome phenotypes, however polycystic ovary syndrome decreased the risk of regression of insulin resistance being temporary (HR 0·30 [95% CI 0·09–0·94]). Baseline fasting insulin concentrations (HR 1·11 [95% CI 1·07–1·15]) and change in fasting insulin concentration from baseline to follow up (1·08 [1·06–1·11]) increased the risk of development of insulin resistance. Glucose concentration 1 h after oral glucose (HR 1·17 [95% CI 1·05–1·31]), glucose concentration after 2 h (1·48 [1·22–1·79]), change in 1 h glucose concentration from baseline (1·18 [1·12–1·25]), and change in 2 h glucose concentration from baseline (1·09 [1·04–1·15]) increased the risk of development of IGT. Glucose concentration after 1 h (HR 1·25 [95% CI 1·05–1·49]) and after 2 h (1·47 [1·19–1·81]), change in 1 h glucose concentration (1·22 [1·11–1·36]), and in 2 h (1·20 [1·08–1·32]) increased the risk of development of diabetes. Development of insulin resistance was more likely in patients with a baseline fasting insulin concentration of more than 8·82 mIU/L (p=0·001) or change in fasting insulin concentration of more than 2·91 mIU/L (p Interpretation Patients with polycystic ovary syndrome seem to have high prevalence of insulin resistance and abnormal glucose metabolism, whereas clinical polycystic ovary syndrome phenotypes seem to have no effect on the prognosis of insulin resistance and abnormal glucose metabolism. Subclinical insulin resistance, abnormal glucose metabolism, baseline impaired insulin or glucose concentrations, or worsening of these factors during follow-up seem to be predictors for development of insulin resistance or abnormal glucose metabolism in patients with polycystic ovary syndrome. Funding National Natural Science Foundation of China and Sun Yat-sen University.

Research Progress of Relationship between Type 1 Diabetes Mellitus and Polycystic Ovary Syndrome

Type 1 Diabetes Mellitus and Polycystic Ovary Syndrome

Advance in Research on Polycystic Ovary Syndrome and Type 1 Diabetes Mellitus

Polycystic ovary syndrome and type 1 diabetes — the current state of knowledge

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

Differences and Similarities Between Abnormal Glucose Tolerance of PCOS and T2DM

Comparison of Metabolic Abnormalities in Patients with New-Diagnostic Polycystic Ovary Syndrome and with New-Diagnostic Type 2 Diabetes Mellitus

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome]

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism

Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature

Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus

Advances in Molecular Genetic Study on PCOS

Prognosis and risk factors of insulin resistance and abnormal glucose metabolism in patients with polycystic ovary syndrome: a single-centre, retrospective, database study

Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)

11Β-Hsd1 ,insulin Resistance and Polycystic Ovary Syndrome

Early Impaired Beta-Cell Function In Chinese Women With Polycystic Ovary Syndrome

Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome

Molecular Mechanism and Biological Effects of Endometrial Insulin Resistance in Polycystic Ovary Syndrome